ADA and histiocytic sarcoma: Receiver operating characteristic analysis identified optimal thresholds of 10.7 μg/mL for ADA concentration and 0.5 L/day for clearance.<h4>Conclusion</h4>Higher ADA concentrations and lower drug clearance are associated with better clinical outcomes in HS.